Robert Koch is probably one of the most important people in all of medicine. Arguably one of the fathers of microbiology, he popularized the idea of his “postulates” which are a set of criteria designed to assess whether a microorganism causes disease (1). His most well known work is with the bacteria bacillus anthracis aka
Category: critical care
Echinocandins. This is the drug we use mostly on the inpatient side for invasive candidiasis. The most well known is micafungin, but analdafungin is another option that is also commonly used. Besides resistance, the issue with echinocandins are the fact they are intravenous drugs, which makes administration of it easy on the inpatient side but
Well, this is new territory. While I typically talk about esoteric/topics infectious diseases docs should be aware of (see: my recent posts on complicated SAB, prior topics tackling dosing of vancomycin and beta-lactamase inhibitors, and acute katayama fever, as examples) I occasionally delve into other more mundane topics (see: neutrophil-lymphocyte ratio). This one is a


